1Saporiti AM, Gomez D, Levalle S, et al. Vaginal carrdidiasis : etiology and sensitivity profile to antifungal agents in clinical use [J].Rev Argent Microbiol,2001,33(4) :217-222.
4Howard BJ,et al. Clinical and pathogenic microbiology[J]. Mosbyyear Book Inc, 1994,616-617.
5Gow NA. Germ tube growth of candida albicans[J]. Curr Top Med Mycol,1997,8(12) :43-45.
6Kreteschmar M, Hobe B, Bertsch T,et al. Grem tube andproteinase activity contribute to virulence of candida albicans in murine peritonitis[J]. Infect Immunol, 1999,67 (12): 6637-6642.
7Steele C, Leigh J, Swoboda R,et al. Growth inhibition of candida by human oral epithelial cells [J]. J Infec Dis, 2000, 182: 1479-1485.
8Barousse MM ,Steele C,Espinosa, et al. growth inhibition of candida by human vaginal epithelial cells [J]. J Infect Dis, 2001,184(11) :1489-1493.
9Hellburg D,zdolsek B,Nilsson S,et al. sexual behavior in women with repeated bouts of vulvovaginal candidiasis [J]. Eur J Epidermiol 1995;11 :575-579.
9Austin MN,Beiqi RH,Mevn LA,et al.M icrobiologic Response to Treatment of Bacterial Clindamycin or Metronidazole[J].Journal of Clinical Microbiology,2005,43:4492-4497(12):5899-5903.
10Correia A,Sampalo P,Almeida J,et al.Study of molecular epidemiology of candidiasis in Poaugal by PCR finger printing of Candida clinical isolates[J].Clin Microbiol,2004,42.
